Rare diseases
Investigational molecules
Locations
Back to Italy215 clinical trials in Orbassano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study of PM54 and pembrolizumab in adults with advanced cancer
ItalyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
ItalyPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ItalyA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
ItalyA study of rilvegostomig and ramucirumab in patients with advanced or metastatic non-small cell lung cancer
ItalyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
ItalyA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
ItalyA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
ItalyEvaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial
ItalyA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
ItalyStudy of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
ItalyA study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lung cancer and mesothelioma treatments, including studies of novel therapeutic combinations and targeted therapies.
Multiple trials evaluating immunotherapy approaches and targeted molecular treatments for advanced stages of cancer.
Research initiatives investigating treatments for blood disorders and related conditions, with particular focus on innovative therapies.
Studies examining new therapeutic approaches for blood disorders and their complications.
Clinical investigations focusing on heart failure prevention and innovative cardiovascular treatments.
Trials evaluating new therapeutic approaches for reducing cardiovascular events and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
